(C) 2021 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,089 JPY | -0.02% | +0.49% | +0.86% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.86% | 41.26B | |
+25.16% | 653B | |
+26.21% | 556B | |
-6.20% | 354B | |
+20.37% | 331B | |
+4.90% | 296B | |
+12.64% | 233B | |
+5.48% | 201B | |
-9.73% | 193B | |
-6.42% | 144B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda's LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV)